Medication info
Elcue Tablets (L-Carnitine)

Elcue Tablets (L-Carnitine)

OTC medicationTabletOral
Ingredient · strength
L-Carnitine›330mg / 1 tablet
Manufacturer / importer
Seoul Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
90 tablets (10 tablets/PTP*9)
Approval status
Active

MFDS item code 200713171 · Notified 2007.12.10

Summary

Main use
Treatment of carnitine deficiency and myocardial metabolic disorders due to ischemic heart disease
Who takes it
Adults
Adult dose
Adults: Administer 2-3g of L-carnitine orally per day in 2-3 divided doses. Adjust the dose as appropriate according to age and symptoms.

Ingredients

Manufacturer
Seoul Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of carnitine deficiency and myocardial metabolic disorders due to ischemic heart disease

  • Primary carnitine deficiency
  • secondary carnitine deficiency
  • myocardial metabolic disorders
  • angina
  • acute myocardial infarction
View approved original text

This medication is used to improve metabolic abnormalities associated with primary and secondary carnitine deficiency. It is also effective in treating myocardial metabolic disorders caused by ischemic heart disease, such as angina and acute myocardial infarction, thus supporting heart function and helping to improve metabolic disorders.

How to take

Adult dose

Adults: Administer 2-3g of L-carnitine orally per day in 2-3 divided doses. Adjust the dose as appropriate according to age and symptoms.

Precautions

This drug should not be used in certain patients. First, patients who have allergic reactions to this drug should avoid taking it. Additionally, this drug contains lactose, so patients with genetic disorders that prevent them from digesting lactose, such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption should not take it. When using this drug, one should also be cautious regarding side effects. Temporary nausea, vomiting, abdominal pain, diarrhea, and changes in body odor may occur. Skin rash, hives, and facial swelling have also been reported, so if these symptoms appear, medical consultation should be sought immediately. Some patients with impaired kidney function may experience muscle weakness, thus caution is necessary. Women who are pregnant or may become pregnant should take this drug only when the benefits of treatment are deemed to outweigh the risks, as its safety during pregnancy has not been fully established. Lactating women should carefully decide whether to take this drug, as it may be transmitted through breast milk.

Side effects

  • temporary area
  • vomiting
  • abdominal pain
  • diarrhea
  • body odor
  • rash
  • hives
  • facial swelling
  • myasthenia

Not everyone experiences these, and they can vary from person to person.

Interactions

Drug interactions

This drug should be used in conjunction with intravenous lipid preparations only after consulting with a physician or pharmacist.

Storage

This drug may be sensitive to air and moisture, so it should be stored in a tightly sealed container. It’s recommended to maintain a storage temperature between 1 degrees and 30 degrees Celsius at room temperature. This will help preserve the drug's efficacy.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

90 tablets (10 tablets/PTP*9)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.